Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO13446 | Stachys recta | Species | Lamiaceae | Eukaryota | UNPD* | |||
NPO15917 | Monilinia fructigena | Species | Sclerotiniaceae | Eukaryota | UNPD* | |||
NPO24656 | Scabiosa olgae | Species | Caprifoliaceae | Eukaryota | UNPD* | |||
NPO15699 | Damnacanthus indicus | Species | Rubiaceae | Eukaryota | HerDing* | |||
NPO6050 | Hymenodictyon excelsum | Species | Rubiaceae | Eukaryota | HerDing* | |||
NPO2868 | Perna viridis | Species | Mytilidae | Eukaryota | UNPD* | |||
NPO861 | Siphonaria funiculata | Species | Siphonariidae | Eukaryota | UNPD* | |||
NPO11734 | Chara corallina | Species | Characeae | Eukaryota | UNPD* | |||
NPO26859 | Solanum curtipes | Species | Solanaceae | Eukaryota | UNPD* | |||
NPO23980 | Rhamnus nakaharai | Species | Rhamnaceae | Eukaryota | UNPD* | |||
NPO16765 | Knoxia valerianoides | Species | Rubiaceae | Eukaryota | TM-MC* | |||
NPO26368 | Fomes tasmanicus | Species | Coriolaceae | Eukaryota | UNPD* | |||
NPO6050 | Hymenodictyon excelsum | Species | Rubiaceae | Eukaryota | TCMID* | |||
NPO15699 | Damnacanthus indicus | Species | Rubiaceae | Eukaryota | TCMID* | |||
NPO13324 | Euphorbia ingens | Species | Euphorbiaceae | Eukaryota | UNPD* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT80 | Cell Line | Raji | Homo sapiens | Activity | = | 70 | % | 2558164 |
NPT2 | Others | Unspecified | Inhibition | = | 100 | % | 2558164 | |
NPT80 | Cell Line | Raji | Homo sapiens | Activity | > | 80 | % | 2558164 |
NPT2 | Others | Unspecified | Inhibition | = | 91.2 | % | 2558164 | |
NPT2 | Others | Unspecified | Inhibition | = | 0 | % | 2558164 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC290954 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC255641 |
0.9861 | High Similarity | NPC147735 |
0.9793 | High Similarity | NPC470569 |
0.979 | High Similarity | NPC190648 |
0.979 | High Similarity | NPC118027 |
0.979 | High Similarity | NPC56433 |
0.979 | High Similarity | NPC312929 |
0.979 | High Similarity | NPC126767 |
0.979 | High Similarity | NPC289042 |
0.979 | High Similarity | NPC245584 |
0.9724 | High Similarity | NPC470568 |
0.966 | High Similarity | NPC208806 |
0.9592 | High Similarity | NPC40356 |
0.9592 | High Similarity | NPC154683 |
0.9589 | High Similarity | NPC294646 |
0.958 | High Similarity | NPC21599 |
0.958 | High Similarity | NPC19896 |
0.958 | High Similarity | NPC193703 |
0.9533 | High Similarity | NPC324736 |
0.9514 | High Similarity | NPC49282 |
0.9463 | High Similarity | NPC66508 |
0.9463 | High Similarity | NPC226656 |
0.9444 | High Similarity | NPC48762 |
0.9396 | High Similarity | NPC107109 |
0.9388 | High Similarity | NPC329933 |
0.9384 | High Similarity | NPC34802 |
0.9379 | High Similarity | NPC34482 |
0.9379 | High Similarity | NPC478019 |
0.9375 | High Similarity | NPC167663 |
0.9338 | High Similarity | NPC178976 |
0.9324 | High Similarity | NPC202595 |
0.9315 | High Similarity | NPC300540 |
0.9315 | High Similarity | NPC470570 |
0.931 | High Similarity | NPC475201 |
0.9306 | High Similarity | NPC182255 |
0.9306 | High Similarity | NPC49108 |
0.9306 | High Similarity | NPC94076 |
0.9272 | High Similarity | NPC77807 |
0.9272 | High Similarity | NPC5379 |
0.9272 | High Similarity | NPC14561 |
0.9267 | High Similarity | NPC214632 |
0.9262 | High Similarity | NPC474417 |
0.9262 | High Similarity | NPC149526 |
0.9262 | High Similarity | NPC230848 |
0.9262 | High Similarity | NPC478148 |
0.9257 | High Similarity | NPC80370 |
0.9241 | High Similarity | NPC84266 |
0.9236 | High Similarity | NPC101366 |
0.9236 | High Similarity | NPC305845 |
0.9236 | High Similarity | NPC204045 |
0.9231 | High Similarity | NPC1268 |
0.9211 | High Similarity | NPC199463 |
0.9211 | High Similarity | NPC37543 |
0.9189 | High Similarity | NPC2569 |
0.9189 | High Similarity | NPC472056 |
0.9189 | High Similarity | NPC172329 |
0.9189 | High Similarity | NPC256672 |
0.9189 | High Similarity | NPC27221 |
0.9189 | High Similarity | NPC7025 |
0.9184 | High Similarity | NPC225173 |
0.9184 | High Similarity | NPC163846 |
0.9172 | High Similarity | NPC268204 |
0.9172 | High Similarity | NPC52789 |
0.9172 | High Similarity | NPC135524 |
0.9172 | High Similarity | NPC55832 |
0.9172 | High Similarity | NPC26051 |
0.9167 | High Similarity | NPC295384 |
0.9167 | High Similarity | NPC472366 |
0.9156 | High Similarity | NPC311740 |
0.9139 | High Similarity | NPC329844 |
0.9139 | High Similarity | NPC169990 |
0.9139 | High Similarity | NPC93552 |
0.9139 | High Similarity | NPC210942 |
0.9139 | High Similarity | NPC135522 |
0.9133 | High Similarity | NPC258249 |
0.9133 | High Similarity | NPC46882 |
0.9133 | High Similarity | NPC232645 |
0.9133 | High Similarity | NPC132990 |
0.9133 | High Similarity | NPC72958 |
0.9128 | High Similarity | NPC158338 |
0.9128 | High Similarity | NPC100985 |
0.9128 | High Similarity | NPC97028 |
0.9128 | High Similarity | NPC65775 |
0.9128 | High Similarity | NPC10027 |
0.9128 | High Similarity | NPC97029 |
0.9128 | High Similarity | NPC65589 |
0.9128 | High Similarity | NPC288036 |
0.9122 | High Similarity | NPC125801 |
0.9122 | High Similarity | NPC7943 |
0.9122 | High Similarity | NPC71055 |
0.9122 | High Similarity | NPC22005 |
0.9122 | High Similarity | NPC123202 |
0.9116 | High Similarity | NPC28632 |
0.9116 | High Similarity | NPC476055 |
0.9103 | High Similarity | NPC219917 |
0.9103 | High Similarity | NPC172250 |
0.9103 | High Similarity | NPC253822 |
0.9103 | High Similarity | NPC215311 |
0.9103 | High Similarity | NPC80962 |
0.9103 | High Similarity | NPC326109 |
0.9103 | High Similarity | NPC48624 |
0.9103 | High Similarity | NPC144118 |
0.9103 | High Similarity | NPC204985 |
0.9103 | High Similarity | NPC213659 |
0.9103 | High Similarity | NPC259166 |
0.9097 | High Similarity | NPC12175 |
0.9097 | High Similarity | NPC309154 |
0.9097 | High Similarity | NPC55162 |
0.9097 | High Similarity | NPC90665 |
0.9097 | High Similarity | NPC138099 |
0.9097 | High Similarity | NPC279668 |
0.9097 | High Similarity | NPC278323 |
0.9097 | High Similarity | NPC190457 |
0.9097 | High Similarity | NPC242994 |
0.9091 | High Similarity | NPC284495 |
0.9091 | High Similarity | NPC472060 |
0.9091 | High Similarity | NPC471905 |
0.9091 | High Similarity | NPC470342 |
0.9091 | High Similarity | NPC53414 |
0.9091 | High Similarity | NPC53206 |
0.9091 | High Similarity | NPC84571 |
0.9091 | High Similarity | NPC472052 |
0.9085 | High Similarity | NPC263483 |
0.9073 | High Similarity | NPC470337 |
0.9073 | High Similarity | NPC149889 |
0.9073 | High Similarity | NPC180944 |
0.9073 | High Similarity | NPC470338 |
0.9073 | High Similarity | NPC312338 |
0.9073 | High Similarity | NPC470340 |
0.9073 | High Similarity | NPC51824 |
0.9073 | High Similarity | NPC87708 |
0.9073 | High Similarity | NPC113608 |
0.9073 | High Similarity | NPC268992 |
0.9048 | High Similarity | NPC475705 |
0.9048 | High Similarity | NPC471906 |
0.9048 | High Similarity | NPC244691 |
0.9048 | High Similarity | NPC117836 |
0.9048 | High Similarity | NPC51887 |
0.9048 | High Similarity | NPC476178 |
0.9041 | High Similarity | NPC469404 |
0.9041 | High Similarity | NPC40118 |
0.9041 | High Similarity | NPC470087 |
0.9041 | High Similarity | NPC321980 |
0.9041 | High Similarity | NPC126534 |
0.9041 | High Similarity | NPC232021 |
0.9038 | High Similarity | NPC101769 |
0.9034 | High Similarity | NPC169452 |
0.9034 | High Similarity | NPC477956 |
0.9034 | High Similarity | NPC470211 |
0.9034 | High Similarity | NPC283429 |
0.9034 | High Similarity | NPC109232 |
0.9034 | High Similarity | NPC181560 |
0.9028 | High Similarity | NPC472419 |
0.9028 | High Similarity | NPC7013 |
0.9028 | High Similarity | NPC162680 |
0.9028 | High Similarity | NPC303644 |
0.9028 | High Similarity | NPC181124 |
0.9028 | High Similarity | NPC116632 |
0.9028 | High Similarity | NPC212767 |
0.9028 | High Similarity | NPC209560 |
0.9028 | High Similarity | NPC294409 |
0.9021 | High Similarity | NPC141934 |
0.9021 | High Similarity | NPC254847 |
0.9013 | High Similarity | NPC155686 |
0.9007 | High Similarity | NPC39819 |
0.9007 | High Similarity | NPC473201 |
0.9007 | High Similarity | NPC302783 |
0.9007 | High Similarity | NPC118427 |
0.8987 | High Similarity | NPC234497 |
0.8987 | High Similarity | NPC470341 |
0.8987 | High Similarity | NPC324522 |
0.8987 | High Similarity | NPC472058 |
0.8987 | High Similarity | NPC105414 |
0.8986 | High Similarity | NPC469764 |
0.898 | High Similarity | NPC3732 |
0.898 | High Similarity | NPC310340 |
0.898 | High Similarity | NPC297600 |
0.8973 | High Similarity | NPC124365 |
0.8973 | High Similarity | NPC265178 |
0.8973 | High Similarity | NPC11056 |
0.8968 | High Similarity | NPC470810 |
0.8966 | High Similarity | NPC472368 |
0.8966 | High Similarity | NPC243528 |
0.8966 | High Similarity | NPC251681 |
0.8966 | High Similarity | NPC21350 |
0.8961 | High Similarity | NPC201127 |
0.8961 | High Similarity | NPC44199 |
0.8961 | High Similarity | NPC212967 |
0.8961 | High Similarity | NPC246647 |
0.8961 | High Similarity | NPC96342 |
0.8961 | High Similarity | NPC164110 |
0.8961 | High Similarity | NPC474637 |
0.8958 | High Similarity | NPC168105 |
0.8958 | High Similarity | NPC477244 |
0.8958 | High Similarity | NPC1486 |
0.8958 | High Similarity | NPC98115 |
0.8958 | High Similarity | NPC235428 |
0.8958 | High Similarity | NPC66349 |
0.8958 | High Similarity | NPC186838 |
0.8958 | High Similarity | NPC477242 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC290954 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9021 | High Similarity | NPD1509 | Clinical (unspecified phase) |
0.8889 | High Similarity | NPD1510 | Phase 2 |
0.8881 | High Similarity | NPD1607 | Approved |
0.8854 | High Similarity | NPD6232 | Discontinued |
0.8805 | High Similarity | NPD7473 | Discontinued |
0.8766 | High Similarity | NPD7819 | Suspended |
0.8741 | High Similarity | NPD1240 | Approved |
0.8671 | High Similarity | NPD6959 | Discontinued |
0.8609 | High Similarity | NPD2533 | Approved |
0.8609 | High Similarity | NPD2532 | Approved |
0.8609 | High Similarity | NPD4378 | Clinical (unspecified phase) |
0.8609 | High Similarity | NPD2534 | Approved |
0.8581 | High Similarity | NPD1549 | Phase 2 |
0.8571 | High Similarity | NPD4380 | Phase 2 |
0.8526 | High Similarity | NPD2393 | Clinical (unspecified phase) |
0.8514 | High Similarity | NPD1550 | Clinical (unspecified phase) |
0.8514 | High Similarity | NPD1552 | Clinical (unspecified phase) |
0.8506 | High Similarity | NPD3226 | Approved |
0.8487 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.8471 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.8456 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.8397 | Intermediate Similarity | NPD7411 | Suspended |
0.8344 | Intermediate Similarity | NPD1934 | Approved |
0.8322 | Intermediate Similarity | NPD2796 | Approved |
0.8301 | Intermediate Similarity | NPD7390 | Discontinued |
0.8252 | Intermediate Similarity | NPD1470 | Approved |
0.825 | Intermediate Similarity | NPD3749 | Approved |
0.825 | Intermediate Similarity | NPD7075 | Discontinued |
0.8242 | Intermediate Similarity | NPD5844 | Phase 1 |
0.8224 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.8224 | Intermediate Similarity | NPD3750 | Approved |
0.82 | Intermediate Similarity | NPD2935 | Discontinued |
0.8187 | Intermediate Similarity | NPD3882 | Suspended |
0.8187 | Intermediate Similarity | NPD7768 | Phase 2 |
0.8182 | Intermediate Similarity | NPD1511 | Approved |
0.8176 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.8176 | Intermediate Similarity | NPD2801 | Approved |
0.8171 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.8146 | Intermediate Similarity | NPD2346 | Discontinued |
0.8113 | Intermediate Similarity | NPD6801 | Discontinued |
0.8101 | Intermediate Similarity | NPD6599 | Discontinued |
0.8092 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.8079 | Intermediate Similarity | NPD1551 | Phase 2 |
0.8077 | Intermediate Similarity | NPD1512 | Approved |
0.8061 | Intermediate Similarity | NPD6166 | Phase 2 |
0.8061 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.8061 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.8039 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.8039 | Intermediate Similarity | NPD2800 | Approved |
0.8037 | Intermediate Similarity | NPD5494 | Approved |
0.8025 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.7988 | Intermediate Similarity | NPD6559 | Discontinued |
0.7987 | Intermediate Similarity | NPD943 | Approved |
0.7972 | Intermediate Similarity | NPD1201 | Approved |
0.7964 | Intermediate Similarity | NPD3818 | Discontinued |
0.7961 | Intermediate Similarity | NPD5404 | Approved |
0.7961 | Intermediate Similarity | NPD5405 | Approved |
0.7961 | Intermediate Similarity | NPD5406 | Approved |
0.7961 | Intermediate Similarity | NPD5408 | Approved |
0.7949 | Intermediate Similarity | NPD6799 | Approved |
0.7939 | Intermediate Similarity | NPD5710 | Approved |
0.7939 | Intermediate Similarity | NPD5711 | Approved |
0.7908 | Intermediate Similarity | NPD2344 | Approved |
0.7895 | Intermediate Similarity | NPD3748 | Approved |
0.7881 | Intermediate Similarity | NPD6651 | Approved |
0.7853 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7843 | Intermediate Similarity | NPD6100 | Approved |
0.7843 | Intermediate Similarity | NPD6099 | Approved |
0.7824 | Intermediate Similarity | NPD5953 | Discontinued |
0.7812 | Intermediate Similarity | NPD5808 | Clinical (unspecified phase) |
0.7811 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.7799 | Intermediate Similarity | NPD920 | Approved |
0.7791 | Intermediate Similarity | NPD3817 | Phase 2 |
0.7778 | Intermediate Similarity | NPD6776 | Approved |
0.7778 | Intermediate Similarity | NPD6781 | Approved |
0.7778 | Intermediate Similarity | NPD6779 | Approved |
0.7778 | Intermediate Similarity | NPD6778 | Approved |
0.7778 | Intermediate Similarity | NPD2799 | Discontinued |
0.7778 | Intermediate Similarity | NPD6777 | Approved |
0.7778 | Intermediate Similarity | NPD6782 | Approved |
0.7778 | Intermediate Similarity | NPD6780 | Approved |
0.7765 | Intermediate Similarity | NPD7074 | Phase 3 |
0.7756 | Intermediate Similarity | NPD7003 | Approved |
0.7756 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7733 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.7707 | Intermediate Similarity | NPD2309 | Approved |
0.7706 | Intermediate Similarity | NPD7054 | Approved |
0.7702 | Intermediate Similarity | NPD7458 | Discontinued |
0.7692 | Intermediate Similarity | NPD1243 | Approved |
0.7688 | Intermediate Similarity | NPD8313 | Approved |
0.7688 | Intermediate Similarity | NPD8312 | Approved |
0.7683 | Intermediate Similarity | NPD5402 | Approved |
0.7673 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.767 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.7669 | Intermediate Similarity | NPD37 | Approved |
0.7667 | Intermediate Similarity | NPD4625 | Phase 3 |
0.7662 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.7661 | Intermediate Similarity | NPD7472 | Approved |
0.7658 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.765 | Intermediate Similarity | NPD7435 | Discontinued |
0.765 | Intermediate Similarity | NPD7698 | Approved |
0.765 | Intermediate Similarity | NPD7696 | Phase 3 |
0.765 | Intermediate Similarity | NPD7697 | Approved |
0.7647 | Intermediate Similarity | NPD3751 | Discontinued |
0.7643 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7634 | Intermediate Similarity | NPD8151 | Discontinued |
0.7622 | Intermediate Similarity | NPD1465 | Phase 2 |
0.7616 | Intermediate Similarity | NPD3764 | Approved |
0.7616 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7616 | Intermediate Similarity | NPD2313 | Discontinued |
0.7616 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.7616 | Intermediate Similarity | NPD6797 | Phase 2 |
0.7609 | Intermediate Similarity | NPD7870 | Phase 2 |
0.7609 | Intermediate Similarity | NPD7871 | Phase 2 |
0.7602 | Intermediate Similarity | NPD7286 | Phase 2 |
0.7584 | Intermediate Similarity | NPD2798 | Approved |
0.7578 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7578 | Intermediate Similarity | NPD5403 | Approved |
0.7574 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7572 | Intermediate Similarity | NPD7251 | Discontinued |
0.7568 | Intermediate Similarity | NPD1283 | Approved |
0.7564 | Intermediate Similarity | NPD1471 | Phase 3 |
0.7562 | Intermediate Similarity | NPD5401 | Approved |
0.7562 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7562 | Intermediate Similarity | NPD7422 | Clinical (unspecified phase) |
0.756 | Intermediate Similarity | NPD1247 | Approved |
0.7557 | Intermediate Similarity | NPD8150 | Discontinued |
0.7551 | Intermediate Similarity | NPD3972 | Approved |
0.7545 | Intermediate Similarity | NPD919 | Approved |
0.753 | Intermediate Similarity | NPD4967 | Phase 2 |
0.753 | Intermediate Similarity | NPD4965 | Approved |
0.753 | Intermediate Similarity | NPD4966 | Approved |
0.7529 | Intermediate Similarity | NPD7808 | Phase 3 |
0.7529 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.7517 | Intermediate Similarity | NPD1651 | Approved |
0.7515 | Intermediate Similarity | NPD7229 | Phase 3 |
0.7514 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD6535 | Approved |
0.75 | Intermediate Similarity | NPD6534 | Approved |
0.7487 | Intermediate Similarity | NPD7701 | Phase 2 |
0.7486 | Intermediate Similarity | NPD7501 | Clinical (unspecified phase) |
0.7483 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7468 | Intermediate Similarity | NPD230 | Phase 1 |
0.745 | Intermediate Similarity | NPD1876 | Approved |
0.7442 | Intermediate Similarity | NPD7177 | Discontinued |
0.744 | Intermediate Similarity | NPD6234 | Discontinued |
0.7431 | Intermediate Similarity | NPD405 | Clinical (unspecified phase) |
0.7407 | Intermediate Similarity | NPD6273 | Approved |
0.7407 | Intermediate Similarity | NPD7874 | Approved |
0.7407 | Intermediate Similarity | NPD7875 | Clinical (unspecified phase) |
0.7405 | Intermediate Similarity | NPD6823 | Phase 2 |
0.74 | Intermediate Similarity | NPD1203 | Approved |
0.7377 | Intermediate Similarity | NPD7700 | Phase 2 |
0.7377 | Intermediate Similarity | NPD7699 | Phase 2 |
0.7368 | Intermediate Similarity | NPD7801 | Approved |
0.7365 | Intermediate Similarity | NPD1281 | Approved |
0.7365 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.7365 | Intermediate Similarity | NPD1610 | Phase 2 |
0.7353 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7351 | Intermediate Similarity | NPD6917 | Clinical (unspecified phase) |
0.7347 | Intermediate Similarity | NPD4626 | Approved |
0.7325 | Intermediate Similarity | NPD4308 | Phase 3 |
0.731 | Intermediate Similarity | NPD3787 | Discontinued |
0.7308 | Intermediate Similarity | NPD4360 | Phase 2 |
0.7308 | Intermediate Similarity | NPD4363 | Phase 3 |
0.7305 | Intermediate Similarity | NPD5761 | Phase 2 |
0.7305 | Intermediate Similarity | NPD5760 | Phase 2 |
0.7285 | Intermediate Similarity | NPD1164 | Approved |
0.7278 | Intermediate Similarity | NPD4287 | Approved |
0.7273 | Intermediate Similarity | NPD6410 | Clinical (unspecified phase) |
0.7273 | Intermediate Similarity | NPD411 | Approved |
0.7268 | Intermediate Similarity | NPD4362 | Clinical (unspecified phase) |
0.7268 | Intermediate Similarity | NPD4361 | Phase 2 |
0.7263 | Intermediate Similarity | NPD8434 | Phase 2 |
0.7262 | Intermediate Similarity | NPD4288 | Approved |
0.7255 | Intermediate Similarity | NPD6832 | Phase 2 |
0.7253 | Intermediate Similarity | NPD6214 | Clinical (unspecified phase) |
0.7253 | Intermediate Similarity | NPD6212 | Phase 3 |
0.7253 | Intermediate Similarity | NPD6213 | Phase 3 |
0.725 | Intermediate Similarity | NPD2654 | Approved |
0.7244 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7241 | Intermediate Similarity | NPD7228 | Approved |
0.7241 | Intermediate Similarity | NPD7893 | Clinical (unspecified phase) |
0.7234 | Intermediate Similarity | NPD8320 | Phase 1 |
0.7234 | Intermediate Similarity | NPD8319 | Approved |
0.7233 | Intermediate Similarity | NPD2343 | Clinical (unspecified phase) |
0.7228 | Intermediate Similarity | NPD8090 | Clinical (unspecified phase) |
0.7215 | Intermediate Similarity | NPD7033 | Discontinued |
0.7211 | Intermediate Similarity | NPD9545 | Approved |
0.7211 | Intermediate Similarity | NPD1548 | Phase 1 |
0.7208 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7207 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.72 | Intermediate Similarity | NPD1608 | Approved |
0.72 | Intermediate Similarity | NPD9717 | Approved |
0.7192 | Intermediate Similarity | NPD9493 | Approved |
0.719 | Intermediate Similarity | NPD9494 | Approved |
0.7188 | Intermediate Similarity | NPD7782 | Clinical (unspecified phase) |
0.7188 | Intermediate Similarity | NPD7783 | Phase 2 |
0.7179 | Intermediate Similarity | NPD2979 | Phase 3 |
0.7179 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
PubChem CID   | 160474 |
ChEMBL   | CHEMBL522932 |
ZINC   |
Molecular Weight:   | 284.07 |
ALogP:   | -1.4884 |
MLogP:   | 2.67 |
XLogP:   | 1.654 |
# Rotatable Bonds:   | 5 |
Polar Surface Area:   | 83.83 |
# H-Bond Aceptor:   | 3 |
# H-Bond Donor:   | 2 |
# Rings:   | 3 |
# Heavy Atoms:   | 21 |